Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (4): 774-778. doi: 10.19723/j.issn.1671-167X.2022.04.032

Previous Articles     Next Articles

茁 刘1,国栋 朱1,世英 唐1,鹏 洪1,勋 赵1,启鸣 张1,丽伟 李2,冉 彭3,志刚 陈1,滨帅 王1,丽 张2,飞龙 杨1,力源 葛1,争辉 孙1,树栋 张1,国良 王1,晓军 田1,洪宪 张1,*(),潞林 马1,*()   

  • Received:2020-02-27 Online:2022-08-18 Published:2022-08-11
  • Contact: 洪宪 张,潞林 马 E-mail:zwl2006@163.com;malulinpku@163.com
  • Supported by:
    the National Natural Science Foundation of China(81972381)

RICH HTML

   

PDF (PC)

CLC Number: 

  • R737.1

Table 1

Preoperative data of elderly patients with renal cancer and venous tumor thrombus"

Patient number Age/years BMI/(kg/m2) Tumor diameter/ cm Gender Side ASA KPS Clinical symptoms TNM Mayo classification
1 77 22.8 2.0 Male Right 2 100 Local symptoms T4N1M0 Ⅲ
2 82 20.2 10.3 Male Right 2 90 Systemic symptoms T3bN1M0 Ⅰ
3 79 23.3 9.6 Male Left 2 100 Systemic symptoms T3bN0M0 0
4 76 23.9 8.9 Male Left 2 100 Both local and systemic symptoms T3cN0M0 Ⅱ
5 82 17.3 9.2 Male Right 2 100 Local symptoms T3bN1M0 0
6 76 22.6 8.1 Male Right 2 100 Local symptoms T3bN0M0 Ⅰ
7 76 22.8 7.1 Male Left 2 95 None T3bN1M0 Ⅰ
8 75 25.9 4.5 Male Left 3 100 Local symptoms T3bN0M0 0
9 76 24.6 5.0 Male Right 2 80 None T3bN0M0 0
10 83 29.7 7.5 Male Right 3 95 Local symptoms T3bN0M0 Ⅰ
11 75 24.7 7.3 Male Right 3 100 Local symptoms T3bN0M0 Ⅳ
12 75 25.0 6.5 Male Right 3 95 Local symptoms T3bN0M0 Ⅱ

Table 2

Intraoperative and postoperative follow-up data of elderly patients with renal cancer and venous tumor thrombus"

Patient number Preoperative serum creatinine/ (μmol/L) Serum creatinine one week after operation/ (μmol/L) Operative time/min Surgical bleeding volume/mL Surgical blood transfusion volume/mL Plasma transfusion volume/mL Intensive care unit length of stay/d Postoperative hospital stayd/d Inferior vena cava resection Pathology type Postoperative complications Clavien classification system Follow up time/ months Survival state
1 134 117 567 800 0 0 1 13 Yes PC Yes 2 23.0 Dead
2 81 109 313 500 0 0 1 5 No CCC No 0 5.0 Dead
3 84 98 265 400 0 0 0 6 No CCC No 0 44.0 Alive
4 113 74 343 3 500 2 000 0 2 10 Yes CCC No 0 14.0 Dead
5 60 62 174 100 0 0 0 7 No CCC No 0 31.0 Alive
6 128 102 244 1 500 1 200 400 0 6 No CCC No 0 30.0 Alive
7 85 94 399 300 0 0 0 8 No CCC No 0 29.0 Alive
8 99 109 137 200 0 0 0 6 Yes CCC No 0 26.0 Alive
9 69 91 108 20 0 0 0 8 No CCC No 0 25.0 Alive
10 81 109 237 200 0 0 1 7 No CCC No 0 25.0 Alive
11 101 84 320 2 100 2 000 800 1 13 No CCC No 0 Loss to follow up
12 92 161 796 3 200 2 000 1 600 6 6 Yes CCC No 0 15.0 Alive
1 Blute ML , Leibovich BC , Lohse CM , et al. The Mayo clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus[J]. BJU Int, 2004, 94 (1): 33- 41.
doi: 10.1111/j.1464-410X.2004.04897.x
2 Al-Otaibi M , Abou-Youssif T , Alkhaldi A , et al. Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome[J]. BJU Int, 2009, 104 (10): 1467- 1470.
doi: 10.1111/j.1464-410X.2009.08575.x
3 彭希哲, 卢敏. 老年人口死亡概率时代变迁与老年定义的重新思考[J]. 人口与经济, 2017, 221 (2): 1- 10.
4 Han KR , Kim HL , Pantuck AJ , et al. Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma[J]. Urology, 2004, 63 (5): 841- 847.
doi: 10.1016/j.urology.2003.12.048
5 Schag CC , Heinrich RL , Ganz PA . Karnofsky performance status revisited: reliability, validity, and guidelines[J]. J Clin Oncol, 1984, 2 (3): 187- 193.
doi: 10.1200/JCO.1984.2.3.187
6 李丽伟, 刘茁, 王国良, 等. 肾癌伴下腔静脉瘤栓合并血栓的多种影像学比较[J]. 北京大学学报(医学版), 2019, 51 (4): 678- 683.
7 李丽伟, 刘茁, 王国良, 等. 肾癌伴下腔静脉瘤栓: 影像评估模型对下腔静脉切除的应用价值[J]. 现代泌尿外科杂志, 2019, 24 (8): 614- 620.
doi: 10.3969/j.issn.1009-8291.2019.08.004
8 刘茁, 马潞林, 田晓军, 等. 根治性肾切除术+下腔静脉癌栓取出术治疗Mayo 0~Ⅳ级下腔静脉癌栓的临床经验[J]. 中华泌尿外科杂志, 2017, 38 (11): 842- 847.
doi: 10.3760/cma.j.issn.1000-6702.2017.11.010
9 田晓军, 邱敏, 刘茁, 等. 微创手术治疗肾癌合并Mayo 0~2级静脉癌栓的单中心研究[J]. 北京大学学报(医学版), 2018, 50 (6): 1053- 1056.
10 刘茁, 田晓军, 马潞林. 根治性肾切除术联合Ⅱ级静脉癌栓取出术的临床麻醉管理[J]. 现代肿瘤医学, 2017, 25 (16): 2672- 2677.
doi: 10.3969/j.issn.1672-4992.2017.16.038
11 刘茁, 马潞林, 田晓军, 等. 腹腔镜和开放肾癌根治性切除+Ⅱ级下腔静脉癌栓取出术例临床分析[J]. 现代泌尿外科杂志, 2017, 22 (8): 603- 607.
doi: 10.3969/j.issn.1009-8291.2017.08.009
12 马潞林, 刘茁. 肾癌并肝段和肝以上下腔静脉癌栓的诊治体会[J]. 中华泌尿外科杂志, 2017, 38 (7): 481- 484.
doi: 10.3760/cma.j.issn.1000-6702.2017.07.001
13 刘茁, 马潞林, 田晓军, 等. 肾癌根治性切除加癌栓取出术治疗Ⅲ级下腔静脉癌栓的手术技术及临床经验[J]. 北京大学学报(医学版), 2017, 49 (4): 597- 602.
doi: 10.3969/j.issn.1671-167X.2017.04.008
14 Liu Z , Tang S , Tian X , et al. Foley catheter-assisted six-step thrombectomy technique in the surgical management of renal cell carcinoma with Mayo level Ⅱ to Ⅳ tumor thrombus[J]. J Int Med Res, 2019, 47 (5): 2104- 2115.
doi: 10.1177/0300060519836912
15 赵勋, 李丽伟, 刘茁, 等. 根治性肾切除术及下腔静脉癌栓取出术治疗Ⅳ级下腔静脉癌栓的手术技术及临床经验[J]. 现代泌尿外科杂志, 2019, 24 (8): 639- 644.
doi: 10.3969/j.issn.1009-8291.2019.08.009
16 刘茁, 马潞林, 王国良, 等. 肾细胞癌合并下腔静脉癌栓患者发生术后早期并发症的临床分析[J]. 国际外科学杂志, 2016, 43 (9): 598- 602.
doi: 10.3760/cma.j.issn.1673-4203.2016.09.007
17 Mandal S , Sankhwar SN , Kathpalia R , et al. Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index[J]. Int Urol Nephrol, 2013, 45 (2): 347- 354.
doi: 10.1007/s11255-013-0399-x
18 Psutka SP , Leibovich BC . Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma[J]. Ther Adv Urol, 2015, 7 (4): 216- 229.
doi: 10.1177/1756287215576443
19 Cost NG , Delacroix SE , J r. , Sleeper JP , et al. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus[J]. Eur Urol, 2011, 59 (6): 912- 918.
doi: 10.1016/j.eururo.2011.02.032
20 Siva S , Pham D , Gill S , et al. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinomav[J]. BJU Int, 2012, 110 (11 Pt B): E737- E743.
21 Zielinski H , Szmigielski S , Petrovich Z . Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma[J]. Am J Clin Oncol, 2000, 23 (1): 6- 12.
doi: 10.1097/00000421-200002000-00002
22 刘茁, 唐世英, 范雯怡, 等. 多学科综合治疗模式在肾癌伴静脉癌栓患者临床诊治中的作用[J]. 现代泌尿外科杂志, 2019, 24 (8): 634- 638.
doi: 10.3969/j.issn.1009-8291.2019.08.008
[1] Zezhen ZHOU,Shaohui DENG,Ye YAN,Fan ZHANG,Yichang HAO,Liyuan GE,Hongxian ZHANG,Guoliang WANG,Shudong ZHANG. Predicting the 3-year tumor-specific survival in patients with T3a non-metastatic renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 673-679.
[2] Binshuai WANG,Min QIU,Qianjin ZHANG,Maofeng TIAN,Lei LIU,Guoliang WANG,Min LU,Xiaojun TIAN,Shudong ZHANG. Experience in diagnosis and treatment of 6 cases of renal Ewing's sarcoma with venous thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 636-639.
[3] Jie YANG,Jieli FENG,Shudong ZHANG,Lulin MA,Qing ZHENG. Clinical effects of transesophageal echocardiography in different surgical methods for nephrectomy combined with Mayo Ⅲ-Ⅳ vena tumor thrombectomy [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 631-635.
[4] Kewei CHEN,Zhuo LIU,Shaohui DENG,Fan ZHANG,Jianfei YE,Guoliang WANG,Shudong ZHANG. Clinical diagnosis and treatment of renal angiomyolipoma with inferior vena cava tumor thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 617-623.
[5] Le YU,Shaohui DENG,Fan ZHANG,Ye YAN,Jianfei YE,Shudong ZHANG. Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 661-666.
[6] Fan SHU,Yichang HAO,Zhanyi ZHANG,Shaohui DENG,Hongxian ZHANG,Lei LIU,Guoliang WANG,Xiaojun TIAN,Lei ZHAO,Lulin MA,Shudong ZHANG. Functional and oncologic outcomes of partial nephrectomy for cystic renal cell carcinoma: A single-center retrospective study [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 667-672.
[7] 树栋 张,睿扬 谢. [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 562-564.
[8] Junyong OU,Kunming NI,Lulin MA,Guoliang WANG,Ye YAN,Bin YANG,Gengwu LI,Haodong SONG,Min LU,Jianfei YE,Shudong ZHANG. Prognostic factors of patients with muscle invasive bladder cancer with intermediate-to-high risk prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 582-588.
[9] Kewei CHEN,Shaohui DENG,Zhuo LIU,Hongxian ZHANG,Lulin MA,Shudong ZHANG. Discussion on the surgical timing of rupture and hemorrhage of renal angiomyolipoma [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 326-331.
[10] Yun-chong LIU,Zong-long WU,Li-yuan GE,Tan DU,Ya-qian WU,Yi-meng SONG,Cheng LIU,Lu-lin MA. Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 781-792.
[11] Huan-rui LIU,Xiang PENG,Sen-lin LI,Xin GOU. Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 793-801.
[12] Zi-xuan XUE,Shi-ying TANG,Min QIU,Cheng LIU,Xiao-jun TIAN,Min LU,Jing-han DONG,Lu-lin MA,Shu-dong ZHANG. Clinicopathologic features and prognosis of young renal tumors with tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 802-811.
[13] Dong LAN,Zhuo LIU,Yu-xuan LI,Guo-liang WANG,Xiao-jun TIAN,Lu-lin MA,Shu-dong ZHANG,Hong-xian ZHANG. Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 825-832.
[14] Min QIU,You-long ZONG,Bin-shuai WANG,Bin YANG,Chu-xiao XU,Zheng-hui SUN,Min LU,Lei ZHAO,Jian LU,Cheng LIU,Xiao-jun TIAN,Lu-lin MA. Treatment outcome of laparoscopic partial nephrectomy in patients with renal tumors of moderate to high complexity [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 833-837.
[15] 聪 田,军 刘,波 杨,佳佳 乔,晓波 黄,清泉 许. [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 948-952.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd